skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 118769 Find in a Library
Title: Pharmaceutical Diversion Program
Corporate Author: Bureau of Justice Assistance
US Dept of Justice
Office of Justice Programs
United States of America
Date Published: 1987
Page Count: 11
Sponsoring Agency: Bureau of Justice Assistance
Washington, DC 20531
National Institute of Justice/
Rockville, MD 20849
NCJRS Photocopy Services
Rockville, MD 20849-6000
Sale Source: National Institute of Justice/
NCJRS paper reproduction
Box 6000, Dept F
Rockville, MD 20849
United States of America

NCJRS Photocopy Services
Box 6000
Rockville, MD 20849-6000
United States of America
Document: PDF
Type: Program Description (Model)
Language: English
Country: United States of America
Annotation: These guidelines are intended for use by States in developing or enhancing programs to control the diversion of legal drugs into the illicit drug market.
Abstract: The abuse of these controlled substances accounted for 54 percent of the Drug Abuse Warning Network mentions in 1985. These diverted drugs become available to drug abusers as a result of illegal activity by registrants, abuse and fraud related to prescriptions, indiscriminate prescribing, and theft. The Pharmaceutical Diversion Program aims to strengthen the role of law enforcement, professional licensing boards, and regulatory agencies in reducing the diversion of legitimately produced drugs. It focuses on data collection and analysis, investigations and professional license discipline, improved regulatory controls, detection of illegal prescriptions, training to improve diversion control, and improved communication. Forms, addresses of Drug Enforcement Administration staff in each State, and list of 4 reports from the United States General Accounting Office are included.
Main Term(s): Illegal dispensing of licit drugs
Index Term(s): Drug law enforcement; Federal programs; Intergovernmental relations; State plans
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.